Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-06-14
1992-02-18
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 514256, 514340, 514369, 514376, 514397, 514451, 514469, 544335, 544336, 544406, 546275, 548183, 548217, 548235, 548236, 548342, 549398, 549462, C07D41312, A61K 3142
Patent
active
050895141
ABSTRACT:
Certain 3-(phenyl, chroman-2-yl, benzofuran-5-yl, or benzoxazol-5-yl)-2-(hydroxy or mercapto)propionic acid derivatives and analogs are useful as hypoglycemic and hypocholesterolemic agents.
REFERENCES:
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4703052 (1987-10-01), Eggler et al.
patent: 4725610 (1988-02-01), Meguro et al.
patent: 4775687 (1988-10-01), Meguro et al.
patent: 4826990 (1989-05-01), Musser et al.
Chem. Abstr. vol. 111, Entry 7394a, Abstracting EP 299620 (1989).
Daus Donald G.
Lumb J. Trevor
McFarlin D. Stuart
Pfizer Inc.
Richardson Peter C.
LandOfFree
3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1823888